These differences align with clinical behavior; IDH-wildtype (usually glioblastomas) are more aggressive and diffusely invasive, consistent with more severe network disintegration, whereas IDH-mutant gliomas (often slower-growing) allow the brain more time to adapt and reorganize its networks [18]. The gene discussed is IDH1; the disease is central nervous system cancer.